GSK3B and chronic myelogenous leukemia, BCR-ABL1 positive: However, there also is genetic evidence that GSK-3β synthesized by CML cells might be involved in TKI resistance evoked by IFN-γ secreted by microenvironmental T- and NK cells [184].